Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Renaissance Holdings ( (HK:1911) ) has issued an update.
China Renaissance Holdings Limited announced that its investee company, Shandong Weigao Blood Purification Products Co., Ltd., has successfully listed on the Shanghai Stock Exchange. Weigao Xuejing, a leader in China’s blood purification industry, has developed core technologies in hemodialysis and peritoneal dialysis, establishing a comprehensive supply chain for blood purification products. The listing underscores the confidence and investment capabilities of China Renaissance’s Huaxing Growth Capital Fund, which had previously led a significant investment in Weigao Xuejing.
More about China Renaissance Holdings
China Renaissance Holdings Limited operates in the financial services industry, focusing on investment management and advisory services. The company manages the Huaxing Growth Capital Fund, which invests in high-growth companies across various sectors.
YTD Price Performance: 7.34%
Average Trading Volume: 795,283
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.76B
Find detailed analytics on 1911 stock on TipRanks’ Stock Analysis page.